Aspen Pharmacare Holdings Limited Provided earnings Guidance for the six months ended 31 December 2019. For the period, Reported and CER revenue growth expected to be of 2% to 4%. Total earnings per share expected to be in the range of 566.2 cents to 592.0 cents. Earnings per share - Continuing operations is expected to be in the range of 523.3 cents to 546.8 cents.